These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25515972)

  • 1. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
    Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
    Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
    Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
    Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
    [No Abstract]   [Full Text] [Related]  

  • 7. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Ji WH; Jiang YH; Ji YL; Li B; Mao WM
    Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
    Sun SY; Chen PP; Meng LX; Li L; Mo ZX; Sun CH; Wang Y; Liang FH
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29905761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
    Matsuda S; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Dis Esophagus; 2014; 27(7):654-61. PubMed ID: 23980622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Change in the Fibrinogen and Albumin Score During Preoperative Treatment in Esophageal Cancer Patients.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Suda K; Wada N; Kitagawa Y
    World J Surg; 2017 Nov; 41(11):2788-2795. PubMed ID: 28608015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
    Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
    Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
    Hamai Y; Hihara J; Emi M; Furukawa T; Ibuki Y; Yamakita I; Kurokawa T; Okada M
    Anticancer Res; 2017 Oct; 37(10):5639-5646. PubMed ID: 28982881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
    Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.